Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

2.

CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.

Ascani S, Massone C, Ferrara G, Rongioletti F, Papini M, Pileri S, Cerroni L.

J Cutan Pathol. 2008 Oct;35(10):911-5. doi: 10.1111/j.1600-0560.2007.00915.x. Epub 2008 May 20.

PMID:
18494823
3.

Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA.

Am J Clin Pathol. 2005 May;123(5):662-75. Review.

PMID:
15981806
4.

CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).

Weaver J, Hsi ED.

J Cutan Pathol. 2008 Oct;35(10):975-7. doi: 10.1111/j.1600-0560.2008.01146.x. Review. No abstract available.

PMID:
18822062
5.

Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.

Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D.

Mod Pathol. 2006 Dec;19(12):1555-62. Epub 2006 Sep 22.

6.

TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.

Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, Casasnovas O, Vergier B, Teitell MA.

Am J Clin Pathol. 2004 Aug;122(2):307-13.

PMID:
15323148
7.

'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.

Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L.

Am J Surg Pathol. 2002 Jul;26(7):852-62.

PMID:
12131152
8.
9.

CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

Herling M, Jones D.

Am J Clin Pathol. 2007 May;127(5):687-700. Review.

PMID:
17439829
10.

CD4+ CD56+ hematodermic neoplasm.

Cibull TL, Thomas AB, O'Malley DP, Billings SD.

Am J Dermatopathol. 2007 Feb;29(1):59-61.

PMID:
17284963
11.

[Hematodermic CD4/CD56 neoplasm].

Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, Déchelotte P, Feuillard J, Durlach A, Vergier B.

Ann Pathol. 2004 Jun;24(3):241-55; quiz 227. Review. French.

PMID:
15480259
13.

[Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].

Machet L, De Muret A, Wiezberka E, Bernez A, Abdallah-Lotf M, Linassier C, Petrella T.

Ann Dermatol Venereol. 2004 Nov;131(11):969-73. French.

PMID:
15602384
14.

Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.

Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA.

Haematologica. 2006 Jan;91(1):143-4.

15.

[Blastic NK-cell lymphoma].

Calvo M, González C, Martín E, Marqués A, Jaén P.

Actas Dermosifiliogr. 2006 May;97(4):253-6. Review. Spanish.

PMID:
16801018
16.

Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.

Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Suefuji H, Suzumiya J, Harada M, Kikuchi M.

Am J Surg Pathol. 2003 Oct;27(10):1366-74.

PMID:
14508398
18.

Cutaneous CD4+/CD56+ hematodermic neoplasm.

Zindanci I, Kavala M, Buyukbabani N, Kocaturk E, Koc M.

Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):723. doi: 10.4103/0378-6323.72471.

19.

CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.

Martín JM, Nicolau MJ, Galán A, Ferrández-Izquierdo A, Ferrer AM, Jordá E.

J Eur Acad Dermatol Venereol. 2006 Oct;20(9):1129-32.

PMID:
16987271
20.

Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?

Dummer R, Cozzio A, Urosevic M.

Exp Dermatol. 2006 May;15(5):392-400. Review.

PMID:
16630081

Supplemental Content

Support Center